Time in Therapeutic Range: Redefining "Optimal" Blood Pressure Control.
作者信息
Bakris George, Sternlicht Hillel
机构信息
University of Chicago Medicine, Department of Medicine, American Heart Association Comprehensive Hypertension Center, Chicago, Illinois, USA.
Veterans Affairs Medical Center and Georgetown University, Washington, DC, USA.
出版信息
J Am Coll Cardiol. 2021 Mar 16;77(10):1300-1301. doi: 10.1016/j.jacc.2021.01.019.
Abstract
摘要
相似文献
1
Time in Therapeutic Range: Redefining "Optimal" Blood Pressure Control.治疗范围内的时间：重新定义“最佳”血压控制
J Am Coll Cardiol. 2021 Mar 16;77(10):1300-1301. doi: 10.1016/j.jacc.2021.01.019.
2
Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.基于10年心血管风险的动态血压监测诊断阈值。
Blood Press Monit. 2007 Dec;12(6):393-5. doi: 10.1097/MBP.0b013e3282f2b53d.
3
Nocturnal Hypertension: Neglected Issue in Comprehensive Hypertension Management.夜间高血压：综合高血压管理中被忽视的问题。
Acta Med Indones. 2016 Jan;48(1):76-82.
4
Redefining Blood Pressure Assessment - The Role of the Ambulatory Blood Pressure Monitoring Study for Drug Safety.重新定义血压评估 - 动态血压监测研究在药物安全性中的作用。
Clin Pharmacol Ther. 2020 Jan;107(1):147-153. doi: 10.1002/cpt.1690. Epub 2019 Nov 30.
5
Blood pressure variability, cardiovascular risk and antihypertensive treatment.
J Hypertens Suppl. 1995 Dec;13(4):S27-34. doi: 10.1097/00004872-199512002-00005.
6
Letter by Rivasi et al Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".里瓦西等人就“强化与标准动态血压控制对老年人脑血管结局的影响（INFINITY）”一文所写的信。
Circulation. 2020 Mar 24;141(12):e650-e651. doi: 10.1161/CIRCULATIONAHA.119.045048. Epub 2020 Mar 23.
7
Evaluating the true prevalence of resistant hypertension.评估顽固性高血压的真实患病率。
Hypertension. 2011 Oct;58(4):e23; author reply e24-5. doi: 10.1161/HYPERTENSIONAHA.111.178111. Epub 2011 Aug 8.
8
Blood pressure variability: a confounder and a cardiovascular risk factor.
Hypertens Res. 2011 Feb;34(2):162-3. doi: 10.1038/hr.2010.223. Epub 2010 Nov 25.
9
Response to Letter Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".
Circulation. 2020 Mar 24;141(12):e652-e653. doi: 10.1161/CIRCULATIONAHA.120.045961. Epub 2020 Mar 23.
10
Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension?动态血压的临床价值：是时候向所有高血压患者推荐了吗？
Clin Exp Nephrol. 2016 Feb;20(1):14-22. doi: 10.1007/s10157-015-1184-1. Epub 2015 Oct 22.
引用本文的文献
1
Time in target range for systolic blood pressure and stroke in people with and without diabetes: the Kailuan prospective cohort study.糖尿病患者和非糖尿病患者的收缩压目标范围内时间与中风：开滦前瞻性队列研究
Front Endocrinol (Lausanne). 2025 May 14;16:1537343. doi: 10.3389/fendo.2025.1537343. eCollection 2025.
2
Long-Term Time in Target Range for Systolic Blood Pressure Since Childhood and Midlife Arterial Stiffness.儿童期以来收缩压处于目标范围内的长期时间与中年期动脉僵硬度
JACC Asia. 2025 Jan 7;5(1):101-112. doi: 10.1016/j.jacasi.2024.10.021. eCollection 2025 Jan.
3
Is calculation of a home blood pressure-based stability score a tool to improve risk stratification in clinical practice?基于家庭血压的稳定性评分计算是否是改善临床实践中风险分层的一种工具？
Hypertens Res. 2025 Feb;48(2):833-835. doi: 10.1038/s41440-024-02021-x. Epub 2024 Nov 14.
4
The association of out-of-office blood pressure time in target range with clinical outcomes.目标范围内的非工作时间血压与临床结局的关联。
Hypertens Res. 2025 Jan;48(1):420-422. doi: 10.1038/s41440-024-01918-x. Epub 2024 Sep 27.
5
Optimizing time-in-target-range assessment for blood pressure: insights from a large-scale study with continual cuffless monitoring.优化血压目标范围内时间评估：来自持续无袖带监测大规模研究的见解
Front Med (Lausanne). 2024 Jun 26;11:1396962. doi: 10.3389/fmed.2024.1396962. eCollection 2024.
6
Combined effect of time in target range and variability of systolic blood pressure on cardiovascular outcomes and mortality in patients with hypertension: A prospective cohort study.目标范围内时间和收缩压变异性对高血压患者心血管结局和死亡率的联合影响：一项前瞻性队列研究。
J Clin Hypertens (Greenwich). 2024 Jun;26(6):714-723. doi: 10.1111/jch.14816. Epub 2024 Apr 23.
7
Time in therapeutic range in context of blood pressure management.血压管理背景下的治疗范围内时间。
Hypertens Res. 2024 Jan;47(1):200-202. doi: 10.1038/s41440-023-01457-x. Epub 2023 Oct 11.
8
Time in therapeutic range: timely in hypertension therapeutics?治疗范围内的时间：高血压治疗是否及时？
J Hum Hypertens. 2023 Mar;37(3):244-247. doi: 10.1038/s41371-022-00800-y. Epub 2023 Jan 6.
9
Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension: The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA): The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA).2022 年越南高血压学会动脉高血压诊断和治疗指南亮点：越南高血压学会（VSH）工作组与越南国家心脏协会（VNHA）的合作：越南高血压学会（VSH）工作组与越南国家心脏协会（VNHA）的合作。
J Clin Hypertens (Greenwich). 2022 Sep;24(9):1121-1138. doi: 10.1111/jch.14580.
10
Guidance for the Interpretation of Continual Cuffless Blood Pressure Data for the Diagnosis and Management of Hypertension.用于高血压诊断和管理的连续无袖带血压数据解读指南。
Front Med Technol. 2022 May 17;4:899143. doi: 10.3389/fmedt.2022.899143. eCollection 2022.
Zotero 插件